The genetics of motor neuron diseases

被引:29
作者
Figlewicz, DA
Orrell, RW
机构
[1] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[2] UCL Royal Free & Univ Coll Med Sch, Univ Dept Clin Neurosci, London NW3 2PF, England
来源
AMYOTROPHIC LATERAL SCLEROSIS | 2003年 / 4卷 / 04期
关键词
ALS; genetics; motor neuron diseases; spinal muscular atrophy; spinobulbar neuronopathy;
D O I
10.1080/14660820310011287
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Motor neuron diseases may be divided into three categories: those with lower motor neuron involvement - spinal muscular atrophy (SMA) and spinobulbar muscular atrophy (SBMA or Kennedy's disease); those with upper motor neuron involvement primary lateral sclerosis (PLS)(1,2) and the spastic paraplegias; and those with combined upper and lower motor neuron involvement - amyotrophic lateral sclerosis (ALS). Other familial motor neuron disorders include hereditary neuronopathies, GM2 gangliosidosis, and possibly the ALS/PD syndrome of Guam. The contribution of genetics to the etiopathogenesis of motor neuron disorder varies considerably, accounting for a high percentage of spinal muscular atrophies, but only a small fraction of cases of ALS. The mode of inheritance also varies, with examples of autosomal dominant (AD), autosomal recessive (AR), or X-linked kindreds. (Tables 1 and 2).
引用
收藏
页码:225 / 231
页数:7
相关论文
共 86 条
[51]  
MILLER RG, 2000, COCHRANE LIB
[52]   MOTOR NEURON DISEASE AND ADULT HEXOSAMINIDASE A DEFICIENCY IN 2 FAMILIES - EVIDENCE FOR MULTISYSTEM DEGENERATION [J].
MITSUMOTO, H ;
SLIMAN, RJ ;
SCHAFER, IA ;
STERNICK, CS ;
KAUFMAN, B ;
WILBOURN, A ;
HORWITZ, SJ .
ANNALS OF NEUROLOGY, 1985, 17 (04) :378-385
[53]   Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis [J].
Mohajeri, MH ;
Figlewicz, DA ;
Bohn, MC .
HUMAN GENE THERAPY, 1999, 10 (11) :1853-1866
[54]  
Morrison BM, 1998, J EXP ZOOL, V282, P32
[55]  
Myerowitz R, 1997, HUM MUTAT, V9, P195, DOI 10.1002/(SICI)1098-1004(1997)9:3<195::AID-HUMU1>3.3.CO
[56]  
2-J
[57]   Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients [J].
Nagai, M ;
Abe, K ;
Okamoto, K ;
Itoyama, Y .
NEUROSCIENCE LETTERS, 1998, 244 (03) :165-168
[58]   Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice [J].
Nagano, S ;
Ogawa, Y ;
Yanagihara, T ;
Sakoda, S .
NEUROSCIENCE LETTERS, 1999, 265 (03) :159-162
[59]   Mutant AP endonuclease in patients with amyotrophic lateral sclerosis [J].
Olkowski, ZL .
NEUROREPORT, 1998, 9 (02) :239-242
[60]  
Orrell RW, 1996, ANN NEUROL, V39, P810